Research graph
References from Resveratrol protects primary hepatocytes against senescence induced by endogenous toxic metabolites. Local targets link to admitted publications; unresolved targets remain external evidence.
Treatment of Acute Liver Failure in Pigs Reduces Hepatocyte Function in a Bioartificial Liver Support System
2002 · External reference
The senescent hepatocyte gene signature in chronic liver disease
2014 · External reference
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease
10.1016/j.jhep.2012.10.031 · 2013 · External reference
Data-driven transcriptomics analysis identifies PCSK9 as a novel key regulator in liver aging
10.1007/s11357-023-00928-w · 2023 · External reference
Population-Based Study of Alcohol-Related Liver Disease in England in 2001-2018: Influence of Socioeconomic Position
10.14309/ajg.0000000000002677 · 2024 · External reference
Decreased PCSK9 expression in human hepatocellular carcinoma
10.1186/s12876-015-0371-6 · 2015 · External reference
ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation
2023 · External reference
Hepatocyte Nuclear Factor 4 Alpha: A Key Regulator of Liver Disease Pathology and Haemostatic Disorders
10.1111/liv.16245 · 2025 · External reference
The senescence-associated secretory phenotype: the dark side of tumor suppression
10.1146/annurev-pathol-121808-102144 · 2010 · External reference
Biological age prediction and NAFLD risk assessment: a machine learning model based on a multicenter population in Nanchang, Jiangxi, China.
10.1186/s12876-025-03752-y · 2025 · External reference
Increased expression of c-Jun in nonalcoholic fatty liver disease
10.1038/labinvest.2014.3 · 2014 · External reference
Bioengineering a cryogel-derived bioartificial liver using particle image velocimetry defined fluid dynamics
2021 · External reference
Hemostasis, bleeding and thrombosis in liver disease
10.15761/jts.1000182 · 2017 · External reference
Mechanisms and Implications of Age-Related Changes in the Liver: Nonalcoholic Fatty Liver Disease in the Elderly
2011 · External reference
Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
10.1186/s12876-019-0972-6 · 2019 · External reference
Resveralogues protect HepG2 cells against cellular senescence induced by hepatotoxic metabolites
2024 · External reference
Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature.
10.3748/wjg.v25.i27.3634 · 2019 · External reference
The hepatic senescence-associated secretory phenotype promotes hepatocarcinogenesis through Bcl3-dependent activation of macrophages
10.1186/s13578-021-00683-5 · 2021 · External reference
Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration
10.3748/wjg.v20.i47.17851 · 2014 · External reference
Transcriptional activation of S100A2 expression by HIF-1α via binding to the hypomethylated hypoxia response elements in HCC cells
10.1002/mc.23393 · 2022 · External reference
Extracorporeal bioartificial liver for treating acute liver diseases.
10.1051/ject/201143195 · 2011 · External reference
Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease
10.1016/j.taap.2013.01.022 · 2013 · External reference
Activation of NF-kappaB, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas
10.1016/s0168-8278(02)00064-8 · 2002 · External reference
P-1 imprints a reversible transcriptional programme of senescent cells
10.1038/s41556-020-0529-5 · 2020 · External reference
Adult liver transplantation: A UK clinical guideline - part 1: pre-operation
2020 · External reference
Changes in Glutathione Content in Liver Diseases: An Update
2021 · External reference
Liver assistive devices in acute liver failure: Current use and future directions
2024 · External reference
Overexpression of KLF4 promotes cell senescence through microRNA-203-survivin-p21 pathway.
10.18632/oncotarget.11200 · 2016 · External reference
Accelerated Biological Aging, Genetic Susceptibility, and Non-Alcoholic Fatty Liver Disease: Two Prospective Cohort Studies.
10.3390/nu17101618 · 2025 · External reference
